While Structure Therapeutics Inc ADR has underperformed by -2.64%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GPCR fell by -19.65%, with highs and lows ranging from $47.48 to $13.22, whereas the simple moving average fell by -23.82% in the last 200 days.
On May 02, 2025, Citigroup started tracking Structure Therapeutics Inc ADR (NASDAQ: GPCR) recommending Buy. A report published by William Blair on February 28, 2025, Initiated its previous ‘Outperform’ rating for GPCR. Stifel also rated GPCR shares as ‘Buy’, setting a target price of $50 on the company’s shares in an initiating report dated January 08, 2025. H.C. Wainwright Initiated an Buy rating on December 04, 2024, and assigned a price target of $80. Morgan Stanley initiated its ‘Overweight’ rating for GPCR, as published in its report on September 23, 2024. JP Morgan’s report from May 21, 2024 suggests a price prediction of $65 for GPCR shares, giving the stock a ‘Overweight’ rating. Cantor Fitzgerald also rated the stock as ‘Overweight’.
Analysis of Structure Therapeutics Inc ADR (GPCR)
To gain a thorough understanding of Structure Therapeutics Inc ADR’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -22.88% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 23.29, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and GPCR is recording an average volume of 985.87K. On a monthly basis, the volatility of the stock is set at 3.20%, whereas on a weekly basis, it is put at 1.97%, with a gain of 3.91% over the past seven days. Furthermore, long-term investors anticipate a median target price of $80.50, showing growth from the present price of $21.79, which can serve as yet another indication of whether GPCR is worth investing in or should be passed over.
How Do You Analyze Structure Therapeutics Inc ADR Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 4.94%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 93.69% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
GPCR shares are owned by institutional investors to the tune of 93.69% at present.
